These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3396975)

  • 21. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
    Guan ZP; Lü HS; Chen YZ; Song YN; Qin XL; Jiang J
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1317-20. PubMed ID: 16271243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis.
    Comerota AJ; Stewart GJ; Alburger PD; Smalley K; White JV
    Surgery; 1989 Aug; 106(2):301-8: discussion 308-9. PubMed ID: 2763031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ; Stewart GJ; White JV
    Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Disposition to thrombosis and thromboembolism prophylaxis with heparin/dihytamine in hip surgery].
    Liedloff H; Mindner K; Brauckhoff KF; Heerdegen R
    Beitr Orthop Traumatol; 1983 Sep; 30(9):458-64. PubMed ID: 6651747
    [No Abstract]   [Full Text] [Related]  

  • 25. Physician practices in the prevention of deep vein thrombosis: the MassPRO DVT Study.
    Anderson FA; Audet AM
    Orthopedics; 1996 Aug; 19 Suppl():9-11. PubMed ID: 8856785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.
    Menzin J; Colditz GA; Regan MM; Richner RE; Oster G
    Arch Intern Med; 1995 Apr; 155(7):757-64. PubMed ID: 7695464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis.
    Lowe GD; Haverkate F; Thompson SG; Turner RM; Bertina RM; Turpie AG; Mannucci PM
    Thromb Haemost; 1999 Jun; 81(6):879-86. PubMed ID: 10404761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and postoperative levels of antithrombin III with special reference to thromboembolism after total hip replacement.
    Fredin H; Nilsson B; Rosberg B; Tengborn L
    Thromb Haemost; 1983 Jun; 49(3):158-61. PubMed ID: 6192514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement.
    J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019
    [No Abstract]   [Full Text] [Related]  

  • 34. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery.
    Poller L; Taberner DA; Sandilands DG; Galasko CS
    Thromb Haemost; 1982 Feb; 47(1):50-3. PubMed ID: 7071805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical versus pharmacologic prevention of deep venous thrombosis.
    Moser G; Krähenbühl B; Barroussel R; Bene JJ; Donath A; Rohner A
    Surg Gynecol Obstet; 1981 Apr; 152(4):448-50. PubMed ID: 7209773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitation of impedance plethysmography in assessing efficacy of dihydroergotamine-heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Parno J; Singer JM
    Thromb Res; 1985 Feb; 37(3):449-58. PubMed ID: 3887636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative blood tests in prediction of postoperative deep vein thrombosis.
    Dhall TZ; Shah GA; Ferguson IA; Ardlie NG; Dhall DP
    Thromb Res; 1982 Jul; 27(2):143-53. PubMed ID: 7135351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement.
    Freick H; Haas S
    Thromb Res; 1991 Jul; 63(1):133-43. PubMed ID: 1658962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
    ten Cate JW
    Haemostasis; 1992; 22(2):109-11. PubMed ID: 1379964
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hip near osteosynthesis, total hip replacement and prevention of thromboembolism (author's transl)].
    Freick H; Graeser W; Hollmann W; Drvendzija M
    Zentralbl Chir; 1979; 104(19):1280-7. PubMed ID: 532401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.